Poxel Presents New Results of Imeglimin Phase 2 and 3 Clinical Studies in Japan at the 64th Annual Meeting of the Japan Diabetes Society (JDS) May 20, 2021
Poxel Announces its Participation at the 64th Annual Meeting of the Japan Diabetes Society May 11, 2021
Poxel Reports Financial Update for Cash and Revenue for the Full Year 2020 and Provides Corporate Update Feb 12, 2021
